Waldencast (WALD) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
Event summary combining transcript, slides, and related documents.
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary
2 Feb, 2026Business model and differentiation
Operates as a multi-brand platform, acquiring and scaling high-growth, purpose-driven brands.
Focuses on asset-light operations, with dedicated teams for each brand to ensure speed and flexibility.
Combines operational discipline of large incumbents with entrepreneurial agility.
Prioritizes brands with authentic consumer followings in attractive market segments.
Seeks complementary brands, especially in professional and consumer beauty categories.
Brand portfolio and acquisition strategy
Current portfolio includes Obagi (medical skincare) and Milk (clean makeup), both leaders in their segments.
Looks for brands with strong consumer loyalty and leadership in high-growth categories.
Open to acquiring brands in makeup, hair, skincare, and fragrance, focusing on favorable structural economics.
Plans to acquire about one brand per year, with significant opportunity for future growth.
Prefers non-celebrity brands unless they have transcended celebrity status.
Brand performance and growth drivers
Milk's sales doubled from $47M in 2022 to $100M in 2023, with EBITDA margin reaching 29% in Q1.
Obagi achieved 81% gross margin in Q1, driven by operational efficiency and product mix.
Milk's growth is fueled by increased marketing, innovation, and international expansion.
Obagi's growth comes from digital channel expansion, increased marketing, and rebuilding Southeast Asia operations.
Both brands have gross margins in line with or better than best-in-class beauty peers.
Latest events from Waldencast
- Flat revenue, lower EBITDA, Obagi growth, Milk Makeup decline, and major debt reduction.WALD
Q4 202513 Mar 2026 - Sales accelerate on innovation and global expansion, with margins and liquidity remaining strong.WALD
Oppenheimer's 24th Annual Consumer Growth and E-Commerce Conference1 Feb 2026 - Q1 net sales up 21%, margins improved, and innovation plus global expansion fuel future growth.WALD
TD Cowen’s 8th Annual Future of the Consumer Conference1 Feb 2026 - Q2 2024 revenue and margins surged, with both brands outpacing market growth and guidance raised.WALD
Q2 202423 Jan 2026 - All directors and the auditor were reappointed by large majorities; no questions raised.WALD
AGM 202614 Jan 2026 - Q3 net revenue rose 30.8% with strong margin expansion and robust brand growth.WALD
Q3 202413 Jan 2026 - Rapidly scaling beauty platform achieves high growth and margins through brand-focused strategy.WALD
27th Annual ICR Conference 202510 Jan 2026 - Strong 2024 revenue and margin growth, with positive 2025 outlook and brand momentum.WALD
Q4 202426 Dec 2025 - Q1 revenue fell 4.1%, but gross margin and Obagi Medical sales improved, supporting growth outlook.WALD
Q1 202526 Dec 2025